Anna E. Hurtley
11Patents
5h-index
30Co-inventors
58Inventor score
Filing activity: May 13, 2019 → Dec 22, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10703733B2 | MCL-1 inhibitors | Human Necessities | 10 | Active |
| US10988451B2 | MCL-1 inhibitors | Human Necessities | 9 | Active |
| US11613546B2 | Substituted pyridotriazine compounds and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US11897892B2 | Substituted pyridotriazine compounds and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US12024528B2 | Bridged tricyclic carbamoylpyridone compounds and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US11643400B2 | MCL-1 inhibitors | Human Necessities | 3 | Active |
| US12054496B2 | Bridged tricyclic carbamoylpyridone compounds and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11667652B2 | MCL1 inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US12187734B2 | Substituted pyridotriazine compounds and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12202842B2 | MCL1 inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12162844B2 | MCL-1 inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.